Le Lézard
Classified in: Health, Business
Subjects: FNC, PDT, ACC

BlueBird Closes Financing of a 165 Million USD Hospital Project in Africa


TEL AVIV, Israel, Jan. 8, 2018 /PRNewswire/ -- BlueBird Finance & Projects reports successful closing of a 165 million USD complex financing package for an EPC Turnkey construction project of an innovative hospital, including medical equipment supply, in Eastern Africa.

BlueBird Finance & Projects logo

The main EPC Contractor is a large international construction company. 

The hospital, the construction of which has recently commenced, shall be the most modern and professional in that country. 

The financing was arranged based on several ECAs (Export Credit Agencies) and other unique commercial instruments, and involved several international lender banks. 

BlueBird has structured the entire package and led the process until closing.  

The borrower of the loan is a government entity. 

This successful closing adds to several financing deals totaling 300 million USD, which BlueBird had closed during 2016. 

BlueBird Finance & Projects, led by Nir Bareket and Ram Shalita with a team of experienced experts, specializes for more than 15 years in arranging complex financing packages for large infrastructure projects in developing countries. Among its clients are large international EPC companies and sponsors.

BlueBird is currently in the final stages of closing several additional projects in Africa in the water treatment and agriculture sectors, which total 140 million USD

In addition, the concrete pipeline for other deals for 2018 amounts to 420 million USD, in the housing, roads and IT sectors. 

For enquiries and additional information, please contact:

Customer Relations
Email: [email protected]

 

SOURCE Bluebird Finance & Projects Ltd


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: